Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Ventricular Tachycardia
- Sponsor
- Universitätsmedizin Mannheim
- Enrollment
- 3200
- Locations
- 1
- Primary Endpoint
- Incidence of ventricular arrythmias (i.e. ventricular fibrillation, ventricular tachykardia, asystole, SCD)
- Last Updated
- 5 years ago
Overview
Brief Summary
The "Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions (RACE-IT)" represents a mono-centric registry of patients being hospitalized suffering from malignant arrythmias (ventricular tachycardia or fibrillation) and sudden cardiac death (SCD).
Detailed findings of patients' clinical outcome regarding mortality and co-morbidities related to the presence of invasive diagnostics or therapies including coronary angiography, percutaneous coronary intervention (PCI), electrophysiological testing (EP), catheter ablation and implanted cardiac devices (e.g. implantable cardioverter-defibrillators) will be documented. Patients will be included when being hospitalized from the year 2004 until today.
Investigators
Michael Behnes
Sub-PI
Universitätsmedizin Mannheim
Eligibility Criteria
Inclusion Criteria
- •Hospitalization due to:
- •ventricular tachycardia
- •ventricular fibrillation
- •sudden cardiac death
Exclusion Criteria
- •not diagnosed with one or more of the above
Outcomes
Primary Outcomes
Incidence of ventricular arrythmias (i.e. ventricular fibrillation, ventricular tachykardia, asystole, SCD)
Time Frame: Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime
Secondary Outcomes
- Incidence of coronary artery disease (CAD) and PCI in patients with VF/VT/SCD(Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime)
- Incidences of recurrent malignant tachycardias, all-cause mortality, arrhythmia-related death, re-PCI/ACVB, re-ablation, further therapy with cardiac devices(Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime)
- Incidence of treatment with cardiac devices (i.e. ICD, CCM, CRT-D)(Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime)
- Incidence of invasive electrophysiologic testing (EP) and catheter ablation(Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime)